Comparative genome analysis provides a foundation for defining salvinorin A biosynthesis in Salvia divinorum
Year: 2026
Type: article
Abstract: The synthesis of salvinorin A by Salvia divinorum is of considerable interest for developing pain relief, anti-opioid addiction and antidepressant medications, but progress has been compromised by limited access to plant material and the complexity of the biosynthetic pathway. Initially using S. splendens, a closely related species, the first steps in the biosynthetic pathway have been elucidated. Here, by preparing a genome sequence for S. divinorum, we are able to undertake comparative genomic analyses with closely related species that do not produce salvinorin A. We establish the genetic basis for additional activities in salvinorin A biosynthesis involving cytochrome P450 and methyl-transferase enzymes. Our genome-based, microevolutionary approach provides insight into how specialized furanoclerodanes of immense pharmacological importance evolved. These results lay a clear path for identification of the remaining steps in the biosynthetic pathway which would allow synthetic production for the development of new therapeutics.
Source: Nature Communications
Authors: Haixiu Li, Yuwei Sun, Wenliang Xu, Baocheng Sun, Song Wu, Chao Li, Junwei Zhao, Cathie Martin, Evangelos C. Tatsis
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,990
Funders: Royal Society, National Natural Science Foundation of China, Chinese Academy of Sciences, Youth Innovation Promotion Association of the Chinese Academy of Sciences, Shanghai Jiao Tong University, Biotechnology and Biological Sciences Research Council, Fundamental Research Funds for the Central Universities, Youth Innovation Promotion Association
Awards: G2361880667, G4679162751, G5518633504
OpenAlex ID: W7140124542
